Calidi Biotherapeutics Inc (CLDI)
2.025
-1.36
(-40.09%)
USD |
NYAM |
Nov 14, 16:00
2.05
+0.02
(+1.23%)
After-Hours: 18:17
Calidi Biotherapeutics Total Assets (Quarterly): 6.431M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.431M |
| March 31, 2024 | 7.405M |
| December 31, 2023 | 10.02M |
| September 30, 2023 | 18.59M |
| Date | Value |
|---|---|
| June 30, 2023 | 10.18M |
| December 31, 2022 | 2.597M |
| September 30, 2022 | 1.618M |
| December 31, 2021 | 3.391M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.618M
Minimum
Sep 2022
18.59M
Maximum
Sep 2023
7.528M
Average
6.918M
Median
Total Assets (Quarterly) Benchmarks
| Lumos Pharma Inc | 21.36M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.18M |
| Shareholders Equity (Quarterly) | -11.75M |